Youssef LA, Spitalnik SL (2017) Iron: a double-edged sword. Transfusion 57(10):2293–2297
Article PubMed PubMed Central Google Scholar
Reith TP, Prah MA, Choi EJ et al (2022) Basal ganglia iron content increases with glioma severity using quantitative susceptibility mapping: A potential biomarker of tumor severity. Tomography 8(2):789–797
Article PubMed PubMed Central Google Scholar
Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045–1060
Article CAS PubMed PubMed Central Google Scholar
Chen Y, Su S, Dai Y et al (2022) Quantitative susceptibility mapping reveals brain iron deficiency in children with attention-deficit/hyperactivity disorder: a whole-brain analysis. Eur Radiol 32(6):3726–3733
Article CAS PubMed Google Scholar
Persson N, Wu J, Zhang Q et al (2015) Age and sex related differences in subcortical brain iron concentrations among healthy adults. NeuroImage 122:385–398
Burgetova R, Dusek P, Burgetova A et al (2021) Age-related magnetic susceptibility changes in deep grey matter and cerebral cortex of normal young and middle-aged adults depicted by whole brain analysis. Quant Imaging Med Surg 11(9):3906–3919
Article PubMed PubMed Central Google Scholar
Ayton S, Wang Y, Diouf I et al (2020) Brain iron is associated with accelerated cognitive decline in people with alzheimer pathology. Mol Psychiatry 25(11):2932–2941
Article CAS PubMed Google Scholar
van den Bent MJ, Geurts M, French PJ et al (2023) Primary brain tumours in adults. Lancet 402(10412):1564–1579
Johnson DR, Sawyer AM, Meyers CA, O’Neill BP, Wefel JS (2012) Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro Oncol 14(6):808–816
Article PubMed PubMed Central Google Scholar
Legendre C, Garcion E (2015) Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies. Trends Endocrinol Metab 26(6):322–331
Article CAS PubMed Google Scholar
Herynek V, Wagnerová D, Malucelli A, Vymazal J, Sameš M, Hájek M (2015) Alterations in the basal ganglia in patients with brain tumours May be due to excessive iron deposition. Oncol Lett 9(1):43–46
Zeng S, Ma H, Xie D et al (2023) Quantitative susceptibility mapping evaluation of glioma. Eur Radiol 33(10):6636–6647
Article CAS PubMed Google Scholar
Langkammer C, Schweser F, Krebs N et al (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 62(3):1593–1599
Nasreddine ZS, Phillips NA, Bédirian V et al (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699
Chen KL, Xu Y, Chu AQ et al (2016) Validation of the Chinese version of Montreal cognitive assessment basic for screening mild cognitive impairment. J Am Geriatr Soc 64(12):e285–e290
QSM Consensus Organization Committee, Bilgic B, Costagli M, Chan KS et al (2024) Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group. Magn Reson Med 91(5):1834–1862
Lang J, Zhao X, Wang X et al (2019) Targeted Co- delivery of the iron chelator deferoxamine and a HIF1α inhibitor impairs pancreatic tumor growth. ACS Nano 13(2):2176–2189
Morales M, Xue X (2021) Targeting iron metabolism in cancer therapy. Theranostics 11(17):8412–8429
Article CAS PubMed PubMed Central Google Scholar
McCarthy RC, Kosman DJ (2014) Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy. Cell Mol Life Sci 72(4):709–727
Article PubMed PubMed Central Google Scholar
Ma Q, Wang X, Li J (2021) LncRNA RP1-86C11.7 exacerbates the glioma progression and oncogenicity by hsa-miR-144-3p/TFRC signaling. Transl Oncol 14(12):101215
Article CAS PubMed PubMed Central Google Scholar
Calzolari A, Larocca LM, Deaglio S et al (2010) Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Oncol 3(2):123–134
Article PubMed PubMed Central Google Scholar
Sousa L, Oliveira MM, Pessôa MTC, Barbosa LA (2020) Iron overload: effects on cellular biochemistry. Clin Chim Acta 504:180–189
Article CAS PubMed Google Scholar
Buijs M, Doan NT, van Rooden S et al (2017) In vivo assessment of iron content of the cerebral cortex in healthy aging using 7-Tesla T2*-weighted phase imaging. Neurobiol Aging 53:20–26
Article CAS PubMed Google Scholar
Madden DJ, Merenstein JL (2023) Quantitative susceptibility mapping of brain iron in healthy aging and cognition. NeuroImage 282:120401
Howard CM, Jain S, Cook AD et al (2022) Cortical iron mediates age-related decline in fluid cognition. Hum Brain Mapp 43(3):1047–1060
Zachariou V, Bauer CE, Seago ER, Raslau FD, Powell DK, Gold BT (2020) Cortical iron disrupts functional connectivity networks supporting working memory performance in older adults. NeuroImage 223:117309
Article CAS PubMed Google Scholar
Matsumoto R, Nair DR, LaPresto E, Bingaman W, Shibasaki H, Lüders HO (2007) Functional connectivity in human cortical motor system: a cortico-cortical evoked potential study. Brain 130(Pt 1):181–197
Rizvi A, Bell K, Yang D et al (2023) Effects of transcranial direct current stimulation over human motor cortex on cognitive-motor and sensory-motor functions. Sci Rep 13(1):20968
Article CAS PubMed PubMed Central Google Scholar
Medaglia JD, Pasqualetti F, Hamilton RH, Thompson-Schill SL, Bassett DS (2017) Brain and cognitive reserve: translation via network control theory. Neurosci Biobehav Rev 75:53–64
Article PubMed PubMed Central Google Scholar
Stam CJ (2014) Modern network science of neurological disorders. Nat Rev Neurosci 15(10):683–695
Article CAS PubMed Google Scholar
Brown PD, Buckner JC, O’Fallon JR et al (2004) Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 59(1):117–125
Gorlia T, van den Bent MJ, Hegi ME et al (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981– 22981/CE.3. Lancet Oncol 9(1):29–38
Pace A, Tanzilli A, Benincasa D (2022) Prognostication in brain tumors. Handb Clin Neurol 190:149–161
Comments (0)